-+ 0.00%
-+ 0.00%
-+ 0.00%

PTC THERAPEUTICS, - EXPECTS ST-920 BLA SUBMISSION TO FDA COMPLETED IN Q4 2026

Reuters·09/21/2026 20:32:28